Press release
Atopic Dermatitis Market Trends That Will Shape the Next Decade: Insights from Product Innovations Transforms The Atopic Dermatitis Market
Atopic Dermatitis
How Large Will the Atopic Dermatitis Market Size By 2025?
The market size for atopic dermatitis has seen significant expansion in the past few years. This expansion is anticipated to continue, with the market size increasing from $8.61 billion in 2024 to $9.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 15.7%. Factors such as improved medical comprehension and awareness, changes in occurrence and prevalence rates, patient advocacy and support networks, the evolution of treatment options, and research and development have all contributed to the growth experienced during the historical period.
How Big Is the Atopic Dermatitis Market Size Expected to Grow by 2029?
The size of the atopic dermatitis market is predicted to increase significantly in the coming times, reaching a total of $17.45 billion by 2029 with a compound annual growth rate (CAGR) of 15.0%. The booming phase predicted for the forecast period can be tied with the breakthroughs in biologic therapies, immunomodulators, small-molecule medications, treatments specifically for children, gene therapy, and precision medicine, coupled with integration into digital health. The future trends in this period would see technological progress in topicals, a greater emphasis on pediatric ad care, improved environmental and allergen handling, and precision tools for diagnosis.
View the full report here:
https://www.thebusinessresearchcompany.com/report/atopic-dermatitis-global-market-report
Which Key Market Drivers Powering Atopic Dermatitis Market Expansion and Growth?
The surge in the frequency of atopic dermatitis, also referred to as eczema, is projected to impel the enhancement of the atopic dermatitis market. This skin issue, identified by dehydrated and itchy skin, sees escalating instances necessitating diagnosis and treatment. Oxford Academic, a publishing organization based in the UK, indicates that the global prevalence of atopic dermatitis (AD) is substantial, impacting roughly 2.6% of the total world's populace, or about 204 million people as of 2024. This number encompasses approximately 101 million grown-ups and 103 million littles ones. Thus, the soaring occurrences of atopic dermatitis are contributing to the augmentation of the atopic dermatitis market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8285&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Atopic Dermatitis Market?
Product innovation is a leading trend rising in popularity within the atopic dermatitis market. Leading businesses in this sector are launching uniquely designed products to increase their market dominance. For instance, in June 2022, Regeneron Pharmaceuticals Inc., a biotech firm based in the US, received FDA authorization for Dupixent (dupilumab). Dupixent is a treatment for children between 6 months to 5 years who are suffering from moderate-to-severe atopic dermatitis. Concurrent use of topical corticosteroids is optional with Dupixent. Dupixent works by limiting the signaling of two prominent sources of Type 2 inflammation (IL-4 and IL-13), which play a vital role in the onset of eosinophilic esophagitis, prurigo nodularis, chronic rhinosinusitis with nasal polyposis, and asthma.
What Are the Emerging Segments in the Atopic Dermatitis Market?
The atopic dermatitis market covered in this report is segmented -
1) By Drug Class: Corticosteroids, Emollients Or Moisturizers, IL-4 And PDE4 Inhibitors, Calcineurin Inhibitors, Antibiotics, Other Drug Classes
2) By Mode of Administration: Topical, Injectable, Oral
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids
2) By Emollients Or Moisturizers: Creams and Lotions, Ointments and Balms, Barrier Repair Creams
3) By IL-4 And PDE4 Inhibitors: Dupilumab (IL-4 Inhibitor), Apremilast (PDE4 Inhibitor)
4) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream
5) By Antibiotics: Topical Antibiotics, Systemic Antibiotics
6) By Other Drug Classes: Antihistamines, Biologics, JAK Inhibitors
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8285&type=smp
Who Are the Global Leaders in the Atopic Dermatitis Market?
Major companies operating in the atopic dermatitis market are Sanofi SA, Meda AB, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma SA, Incyte Corporation, Bayer AG, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, F Hoffmann-La Roche AG, LEO Pharma A/S, Teva Pharmaceutical Industries Ltd., Mylan MV, Allergan PLC, Encore Dermatology Inc., Menlo Therapeutics Inc., Johnson & Johnson, Merck & Co Inc., Roche Holding AG, Valeant Pharmaceuticals International Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eisai Co. Ltd., Gilead Sciences Inc., Ipsen Biopharmaceuticals Inc., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals Limited
Which are the Top Profitable Regional Markets for the Atopic Dermatitis Industry?
North America was the largest region in the atopic dermatitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atopic dermatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8285
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atopic Dermatitis Market Trends That Will Shape the Next Decade: Insights from Product Innovations Transforms The Atopic Dermatitis Market here
News-ID: 4083647 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Atopic
Rising Prevalence Of Atopic Dermatitis Is A Key Catalyst For The Growth Of The A …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Atopic Dermatitis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The scope of the atopic dermatitis market has experienced substantial expansion recently, projected to increase from $8.61 billion in 2024 to reach $9.88 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.7%;…
Atopic Dermatitis Pipeline Outlook Report 2024
DelveInsight's, "Atopic Dermatitis Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the pipeline drug profiles, including Atopic Dermatitis clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Atopic Dermatitis Pipeline…
Advanced Therapy Revolutionizes Atopic Dermatitis Market Prospects
The atopic dermatitis market size is expected to be valued at USD 15.42 Billion in 2024 and reach USD 30.5 Billion by 2029, growing at a CAGR of 14.5 % from 2024 to 2029.
Atopic dermatitis, known as eczema, is a prevalent skin condition marked by red, inflamed, and itchy skin. It is a chronic condition commonly seen in children but can also impact adults. Atopic dermatitis is thought to result…
Atopic Dermatitis - Drug Pipeline Landscape, 2023
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may crak and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger…
Atopic Dermatitis - Drug Pipeline Landscape, 2022
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may cr*ck and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness.
Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an…
Atopic Dermatitis (Atopic Eczema) Treatment Market Business Growth And Industry …
Precision Business Insights published a research report on “Atopic Dermatitis (Atopic Eczema) Treatment Market by Drug type (Corticosteroids, Calcineurin Inhibitors, Immunosuppressants, Phosphodiesterase type 4 (PDE-4) Inhibitors, Antibiotics, Antihistamines, Emollients), Route of administration (Oral, Topical, Parenteral), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography - Global/Region/Country Forecast to 2027”.
In people who suffer from atopic dermatitis, allergies play a big influence. When the patient is exposed to…
